Historically, urologists do not recommend external beam radiotherapy for patients with renal cell carcinoma. But the progresses of radiotherapy have permitted the use of a high-precision stereotactic ablative radiotherapy in hypofractioned scheduling. It seems a therapeutic alternative of for elderly and frail patients which are not surgical candidates. The rational is to offer a single session of 26Gy or a short curse of 40Gy, delivered only on fi ve sessions, in an outpatient treatment. The endpoints must be tumor size reduction or no tumoral progression, being interesting for symptomatic candidates. The results are acceptable and side effects are tolerable. In face recent reports in the literature, Correa and several international key opinion leaders, published this metanalysis, that evaluated 26 selected studies. Reading this article, we can ourselves updated on this therapeutic approach, destinated for a subgroup of patients that usually has almost none options of treatment.
